Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
29.06
+0.86 (3.05%)
At close: Apr 14, 2026, 4:00 PM EDT
29.46
+0.40 (1.38%)
Pre-market: Apr 15, 2026, 5:41 AM EDT

Genmab Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,2041,326817999.61599.17
Depreciation & Amortization
71604352.137.93
Stock-Based Compensation
1281058563.1947.41
Other Adjustments
28-20186-56.85-120.66
Change in Receivables
-166-230116-305.57-154.3
Changes in Inventories
-9-1-8--
Changes in Accounts Payable
4001229040.7346.49
Changes in Income Taxes Payable
-460-50-155-227.85-113.47
Changes in Other Operating Activities
-10-5-3-2.3-109.65
Operating Cash Flow
1,1861,1261,071563.06340.72
Operating Cash Flow Growth
5.33%5.13%90.21%65.26%-67.73%
Capital Expenditures
-37-27-53-45.63-38.54
Purchases of Intangible Assets
-18-17-1--
Purchases of Investments
-995-1,256-1,582-1,396-2,388
Proceeds from Sale of Investments
2,6221,6361,4511,0442,280
Payments for Business Acquisitions
-7,215-1,783---
Investing Cash Flow
-5,643-1,447-185-397.4-146.96
Long-Term Debt Issued
5,500----
Net Long-Term Debt Issued (Repaid)
5,500----
Issuance of Common Stock
23192140.320.65
Repurchase of Common Stock
-448-576-96-143.36-76
Net Common Stock Issued (Repurchased)
-425-557-75-103.06-55.36
Other Financing Activities
-286-9-14-10.51-8.87
Financing Cash Flow
4,789-566-89-113.56-64.23
Effect of Exchange Rate Changes on Cash and Cash Equivalents
363-1282.62129.99
Net Cash Flow
332-88779752.1129.53
Free Cash Flow
1,1491,0991,018517.44302.18
Free Cash Flow Growth
4.55%7.96%96.74%71.23%-69.95%
FCF Margin
30.89%35.21%42.59%24.78%23.48%
Free Cash Flow Per Share
1.831.701.540.780.46
Levered Free Cash Flow
6,4181,232545601.78274.96
Unlevered Free Cash Flow
806.82929.53510.25525.17163.58
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q